Ignite Creation Date:
2025-12-25 @ 2:59 AM
Ignite Modification Date:
2026-03-09 @ 5:33 AM
Study NCT ID:
NCT02925533
Status:
TERMINATED
Last Update Posted:
2017-06-27
First Post:
2016-10-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ph 1B B-701 in Combination With Pembrolizumab in Metastatic Transitional Cell Carcinoma of the Urothelial Tract
Sponsor:
Mark Pomerantz, MD
Organization: